Search

Your search keyword '"Ribaudo, Heather J"' showing total 15 results
Start Over Author "Ribaudo, Heather J" Database Gale General OneFile
15 results on '"Ribaudo, Heather J"'

1. Instantaneous inhibitory potential is similar to inhibitory quotient at predicting HIV-1 response to antiretroviral therapy

Author

Henrich, Timothy J., Ribaudo, Heather J., and Kuritzkes, Daniel R.

Subjects
HIV infection -- Care and treatment, HIV infection -- Patient outcomes, HIV infection -- Research, Antiviral agents -- Dosage and administration, Antiviral agents -- Research, Immune response -- Research, Dose-response relationship (Biochemistry) -- Research, Health, Health care industry
Published
2010

2. Substitution of nevirapine because of efavirenz toxicity in AIDS clinical trials group A5095

Author

Schouten, Jeffrey T., Krambrink, Amy, Ribaudo, Heather J., Kmack, Anne, Webb, Nancy, Shikuma, Cecilia, Kuritzkes, Daniel R., and Gulick, Roy M.

Subjects
Nevirapine -- Dosage and administration, Nevirapine -- Research, Efavirenz -- Complications and side effects, Efavirenz -- Research, AIDS (Disease) -- Care and treatment, AIDS (Disease) -- Patient outcomes, AIDS (Disease) -- Research, Health, Health care industry
Published
2010

3. Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 infection (AIDS clinical trials group study A5095)

Author

Shikuma, Cecilia M., Yang Yang, Glesby, Marshall J., Meyer, William A., III, Tashima, Karen T., Ribaudo, Heather J., Webb, Nancy, Bastow, Barbara, Kuritzkes, Daniel R., and Gulick, Roy M.

Subjects
HIV infection -- Care and treatment, Protease inhibitors -- Complications and side effects, Drug metabolism -- Research, Health
Abstract

Metabolic changes are assessed after initiation of protease inhibitor (PI)-sparing regimes in antiretroviral-naive patients. The results have shown mild increases in glucose and decreases in insulin sensitivity in all regimens, whereas lipids are modestly higher in the 3-drug efavirenz (EFV)-containing arms and the metabolic dysfunctions of concern after the PI-sparing therapies are abnormal total cholesterol (TC) and lower high-density lipoprotein cholesterol (HDL-C) levels.

Published
2007

4. Three- versus four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: A randomized controlled trial

Author

Gulick, Roy M., Ribaudo, Heather J., Shikuma, Cecilia M., Lalama, Christina, Schackman, Bruce R., Meyer, William A., III, Acosta, Edward P., Schouten, Jeffrey, Squires, Kathleen E., Pilcher, Christopher D., Murphy, Robert L., Koletar, Susan L., Carlson, Margrit, Reichman, Richard C., Bastow, Barbara, Klingman, Karin L., and Kuritzkes, Daniel R.

Subjects
Antiviral agents -- Complications and side effects, Antiviral agents -- Research, HIV infection -- Drug therapy, Clinical trials
Abstract

The safety/efficacy of 3-drug versus 4-drug regimens for initial treatment of HIV-1 infection are compared. It is demonstrated that there is no significant differences, over 3 years, in safety/efficacy between the 3-drug versus 4-drug antiretroviral regimens for the initial treatment of HIV-1 infection.

Published
2006

7. Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection

Author

Gulick, Roy M., Meyer, William A., Ribaudo, Heather J., Schackman, Bruce R., Shikuma, Cecilia M., Lustgarten, Stephanie, Murphy, Robert L., Witt, Mallory D., Squires, Kathleen E., and Snyder, Sally

Subjects
Reverse transcriptase inhibitors -- Evaluation, Antiviral agents -- Evaluation, HIV infection -- Drug therapy
Abstract

A double-blind study, involving three antiretroviral regimens for the initial treatment of patients infected with HIV-1:zidovudine-lamivudine-abacavir, zidovudine-lamivudine plus efavirenz, and zidovudine-lamivudine-abacavir plus efavirenz, is presented.

Published
2004

8. Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms of efavirenz pharmacokinetics and treatment response: an AIDS clinical trials group study

Author

Ribaudo, Heather J., Liu, Huan, Schwab, Matthias, Schaeffeler, Elke, Eichelbaum, Michel, Motsinger-Reit, Alison A., Ritchie, Marylyn D., Zanger, Ulrich M., Acosta, Edward P., Morse, Gene D., Gulick, Roy M., Robbins, Gregory K., Clifford, David, and Haas, David W.

Subjects
HIV infection -- Care and treatment, HIV infection -- Patient outcomes, HIV infection -- Research, Efavirenz -- Dosage and administration, Efavirenz -- Research, Pharmacokinetics -- Research, Genetic polymorphisms -- Analysis, Health
Published
2010

9. Pre-existing minority drug-resistant HIV-1 variants, adherence, and risk of antiretroviral treatment failure

Author

Paredes, Roger, Lalama, Christina M., Ribaudo, Heather J., Schackman, Bruce R., Shikuma, Cecilia, Giguel, Francoise, Meyer, William A., III, Johnson, Victoria A., Fiscus, Susan A., D'Aguila, Richard T., Gulick, Roy M., and Kuritzkes, Daniel R.

Subjects
HIV infection -- Drug therapy, HIV infection -- Genetic aspects, HIV infection -- Patient outcomes, HIV infection -- Research, Viral drug resistance -- Risk factors, Viral drug resistance -- Demographic aspects, Viral drug resistance -- Genetic aspects, Viral drug resistance -- Research, Patient compliance -- Research, Health
Published
2010

11. Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects

Author

Kuritzkes, Daniel R., Lalama, Christina M., Ribaudo, Heather J., Marcial, Michelle, Meyer, William A., III, Shikuma, Cecilia, Johnson, Victoria A., Fiscus, Susan A., D'Aquila, Richard T., Schackman, Bruce R., Acosta, Edward P., and Gulick, Roy M.

Subjects
HIV infection -- Care and treatment, Efavirenz -- Dosage and administration, Drug resistance -- Research, Virulence (Microbiology) -- Research, Health
Published
2008

12. Plasma HIV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens: ACTG A5166s

Author

Kuritzkes, Daniel R., Ribaudo, Heather J., Squires, Kathleen E., Koletar, Susan L., Santana, Jorge, Riddler, Sharon A., Reichman, Richard, Shikuma, Cecilia, Meyer, William A., III, Klingman, Karin L., and Gulick, Roy M.

Subjects
HIV infection -- Care and treatment, HIV infection -- Patient outcomes, Antiviral agents -- Research, Nucleosides -- Research, Blood plasma -- Analysis, Health
Published
2007

13. A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease

Author

Fischl, Margaret A., Ribaudo, Heather J., Collier, Ann C., Erice, Alejo, Giuliano, Marina, Dehlinger, Marjorie, Eron, Joseph J., Jr., Saag, Michael S., Hammer, Scott M., Vella, Stefano, Morse, Gene D., and Feinberg, Judith E.

Subjects
Nelfinavir -- Dosage and administration, Nelfinavir -- Physiological aspects, Indinavir -- Dosage and administration, Indinavir -- Physiological aspects, Zidovudine -- Dosage and administration, Zidovudine -- Physiological aspects, Lamivudine -- Dosage and administration, Lamivudine -- Physiological aspects, HIV (Viruses) -- Health aspects, HIV (Viruses) -- Causes of, HIV (Viruses) -- Prevention, HIV (Viruses) -- Care and treatment, Highly active antiretroviral therapy -- Methods, HIV patients -- Health aspects, HIV patients -- Care and treatment, HIV patients -- Drug therapy, Airborne infection -- Research, Airborne infection -- Causes of, Health
Published
2003

15. The implications of a high allelic frequency of CYP2B6 G516T in ethnic Chinese persons

Author

Tong, Kenneth, He, Ming-Liang, Lin, Che-Kit, Guo, Liping, Kung, Hsiang-Fu, Sung, Joseph J. Y., Lee, Shui-Shan, Ribaudo, Heather J., Haas, David W., and Acosta, Edward P.

Subjects
Allelomorphism -- Research, Chinese Americans -- Research, Chinese Americans -- Health aspects, HIV patients -- Research, HIV patients -- Health aspects, Health, Health care industry
Published
2006

Catalog

Books, media, physical & digital resources
See catalog results